The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

Erdem, Selcuk; Yegen, Gulcin; Telci, Dilek; Yildiz, İbrahim; Tefik, Tzevat; Issever, Halim; Kilicaslan, Isin; Sanli, Oner

doi:10.1007/s00345-014-1462-7

The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

Atıf İçin Kopyala

Erdem S., Yegen G., Telci D., Yildiz İ. , Tefik T., Issever H., et al.

WORLD JOURNAL OF UROLOGY, cilt.33, ss.1553-1560, 2015 (SCI İndekslerine Giren Dergi)

Cilt numarası: 33 Konu: 10
Basım Tarihi: 2015
Doi Numarası: 10.1007/s00345-014-1462-7
Dergi Adı: WORLD JOURNAL OF UROLOGY
Sayfa Sayısı: ss.1553-1560

Özet

The aim of this study was to investigate the role of transglutaminase 2(TG2) in renal cell carcinoma (RCC) by comparing the immunohistochemistry staining of primary and metastatic tumor tissues.